Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance (Q42491293)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance |
scientific article |
Statements
1 reference
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance (English)
1 reference
Annamaria Colao
1 reference
Gaetano Lombardi
1 reference
Rosario Pivonello
1 reference
Renata S Auriemma
1 reference
Maria Cristina De Martino
1 reference
Francesco Briganti
1 reference
Fabio Tortora
1 reference
Pia Burman
1 reference
Ione A Kourides
1 reference
Christian J Strasburger
1 reference
1 March 2006
1 reference
1 reference
Identifiers
1 reference